On September 8, Rittal Healthcare announced the completion of the pre-A round of financing of tens of millions of yuan. This round of financing was invested by Bunqin Venture Capital. This round of financing will be used for AI imaging diagnosis research and development, next-generation dynamic imaging technology iteration, and overseas marketing and global market expansion.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.